Back to top
more

Celanese (CE)

(Delayed Data from NYSE)

$156.53 USD

156.53
662,551

-0.81 (-0.51%)

Updated May 20, 2024 04:00 PM ET

After-Market: $156.51 -0.02 (-0.01%) 7:30 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (153 out of 249)

Industry: Chemical - Specialty

Better trading starts here.

Zacks News

Celanese (CE) Gains on Acquisitions & Productivity Actions

While Celanese (CE) faces headwinds from weaker demand and destocking, it benefits from productivity measures, investments in organic projects and strategic acquisitions.

Celanese (CE) Up 15% in 3 Months: What's Driving the Stock?

Celanese (CE) benefits from productivity measures, investments in organic projects and strategic acquisitions.

Why Is Celanese (CE) Up 14.4% Since Last Earnings Report?

Celanese (CE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Retain Celanese (CE) in Your Portfolio

Celanese (CE) gains on productivity actions, investments in high-return organic projects and synergies of acquisitions.

Celanese's (CE) Q1 Earnings & Revenues Surpass Estimates

Celanese (CE) witnesses increased volumes due to an additional month of sales from the Mobility & Materials acquisition as well as demand recovery in Europe and Asia in Q1.

Celanese (CE) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Celanese (CE) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Celanese (CE) Q1 Earnings and Revenues Top Estimates

Celanese (CE) delivered earnings and revenue surprises of 21.08% and 4.89%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Mayur Thaker headshot

Stocks Enter Sixth Week of Low Volatility as Earnings Beat Expectations

April jobs beat expectations, but primary economic trends remain bearish.

Celanese (CE) to Report Q1 Earnings: What's in the Offing?

Celanese (CE) is likely to have gained from pricing and productivity actions amid headwinds from higher input costs and destocking in Q1.

DOW Selects Linde for Ethylene Cracker and Derivatives Site

The ethylene cracker and derivatives complex will decarbonize roughly 20% of Dow's (DOW) global ethylene capacity while increasing its global polyethylene supply by around 15%.

Air Products (APD) to Build Hydrogen Refueling Station in Alberta

The hydrogen refueling station will be Air Products' (APD) first in Canada. It will also be Alberta's first commercial-scale hydrogen refueling station.

Celanese (CE) Up 24% in 6 Months: What's Driving the Stock?

Celanese (CE) gains on cost and productivity actions, investments in high-return projects and contributions of acquisitions.

Celanese (CE) & Glaukos Join Forces for Glaucoma Treatment

Celanese (CE) partners with Glaukos to provide VitalDose for sustained release treatment for glaucoma.

Is Invesco S&P 500 Equal Weight Materials ETF (RTM) a Strong ETF Right Now?

Smart Beta ETF report for RTM

Is First Trust Large Cap Value AlphaDEX ETF (FTA) a Strong ETF Right Now?

Smart Beta ETF report for FTA

Here's Why You Should Retain Celanese (CE) in Your Portfolio

Celanese (CE) gains on productivity actions, investments in high-return organic projects and synergies of acquisitions.

Is First Trust Large Cap Core AlphaDEX ETF (FEX) a Strong ETF Right Now?

Smart Beta ETF report for FEX

Is First Trust Multi Cap Value AlphaDEX ETF (FAB) a Strong ETF Right Now?

Smart Beta ETF report for FAB

Should First Trust Large Cap Value AlphaDEX ETF (FTA) Be on Your Investing Radar?

Style Box ETF report for FTA

Celanese (CE) Partners With Alessa for Drug Delivery System

Celanese (CE) forms an alliance with Alessa Therapeutics to develop an innovative drug delivery system for oncology patients.

Celanese (CE) & Mitsui Ink New Partnership, Extend Fairway JV

Celanese (CE) joins forces with Mitsui to form a new Food Ingredient joint venture to strengthen its strategic partnership with the latter.

Celanese's (CE) Earnings and Revenues Miss Estimates in Q4

Input cost inflation, supply chain disruptions and consumer destocking weigh on fourth-quarter performance of Celanese (CE).

Celanese (CE) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Celanese (CE) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.